Synthetic cannabinoid (K2) use in pediatric patients and cardiovascular events: A place for pericarditis and myopericarditis?

J Pediatr. 2015 Dec;167(6):1454. doi: 10.1016/j.jpeds.2015.08.063. Epub 2015 Oct 3.

¹ Department of Cardiology, Centre Hospitalier Universitaire de Caen, Caen, France; Department of Pharmacology, Centre Hospitalier Universitaire de Caen, Caen, France; EA 4650 Signaling, electrophysiology and imaging of myocardial ischemia-reperfusion lesions, Université de Caen Basse-Normandie, Caen, France; Medical School, Université de Caen Basse-Normandie, Caen, France.
² Department of Pharmacology, Centre Hospitalier Universitaire de Caen, Caen, France.
³ Department of Pharmacology, Centre Hospitalier Universitaire de Caen, Caen, France; Center for Evaluation and Information on Pharmacodependance-Addictovigilance (CEIP-A), Centre Hospitalier Universitaire de Caen, Caen, France.
⁴ Department of Pharmacology, Centre Hospitalier Universitaire de Caen, Caen, France; Medical School, Université de Caen Basse-Normandie, Caen, France; Center for Evaluation and Information on Pharmacodependance-Addictovigilance (CEIP-A), Centre Hospitalier Universitaire de Caen, Caen, France; INSERM U1075, Mobilités: Attention, Orientation et Chronobiologie, Université de Caen Basse-Normandie, Caen, France.

No abstract available

Publication types